We are live on
!
Find out more
Instil Bio
Fund managers haven’t disclosed any holdings of TIL yet.
TIL Hedge Fund Activity: Q1 2026 in Review
32 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q1 2026, worth a combined $34.6M — down 29% from $48.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TIL positions and 6 closed out — a net gain of 4 holders — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Kalehua Capital Management, opening a new position worth an estimated $1.48M. The largest seller was Siren LLC, exiting entirely with an estimated $2.24M sold.
- 32 institutional investors held Instil Bio (TIL) as of Q1 2026, up from 29 in Q4 2025.
- Funds reported $34.6M of Instil Bio stock for Q1 2026, down 29% quarter-over-quarter.
- 10 funds opened new Instil Bio positions in Q1 2026 and 6 closed out, a net change of +4 holders.
- The largest Instil Bio buyer in Q1 2026 was Kalehua Capital Management, an estimated $1.48M added.
- The largest Instil Bio seller in Q1 2026 was Siren LLC, an estimated $2.24M sold.
Based on aggregated 13F filings for Q1 2026.